The natural history of severe, symptomatic aortic stenosis has been well documented. However, the natural history of moderate aortic stenosis remains poorly understood. Therefore, a group of 66 patients was identified who had a diagnosis of moderate aortic stenosis at the time of cardiac catheterization (aortic valve area 0.7 to 1.2 cm 2 ) and who did not have surgical therapy during the 1st 180 days after cardiac catheterization. During a mean follow.up period of 3S months, 14 patients died of causes attributed to aortic stenosis and 21 underwent aortic valve replacement.
The natural history of severe symptomatic aortic stenosis has been well documented 0-5). The natural history of mild or moderate aortic stenosis remains poorly understood. Clinical studies (6) (7) (8) (9) (10) (11) (12) performed before the availability of cardiac catheterization attempted to determine the natural history of aortic stenosis but lacked hemodynamic information. Subsequent studies (4, 5, (13) (14) (15) (16) (17) (18) (19) (20) performed after the availability of cardiac catheterization and aortic valve replacement have been difficult to interpret because the natural history of many patients with aortic stenosis has been interrupted by valve replacement.
The treatment of patients with aortic stenosis, including the timing of valve replacement, requires accurate knowledge of the natural history of the condition so that patients are not exposed prematurely to the recognized complications of aortic valve replacement. This study was performed to characterize the natural history of moderate aortic stenosis by examining the outcome of a large group of patients who had been found to have moderate aortic stenosis at cardiac catheterization.
Methods
Patient selection. Patients for this study were selected from those undergoing cardiac catheterization at the Mayo The estimated probability for remaining free of any complication of aortic stenosis at the end of the first 4 years was 59%. Symptomatic patients with decreased ejection fraction or hemodynamic evidence of left ventricular decompensation were at greater risk for these complications. It is concluded that patients with moderate aortic stenosis are at significant risk for the development of complications.
(J Am Coli CardioI1991; 17:313-9) Clinic between 1980 and 1985 on the basis of having moderate aortic stenosis, defined as an aortic valve area of 0.7 to 1.2 cm 2 as determined at cardiac catheterization. Patients were excluded if any of the following were present: congenital heart disease other than congenital bicuspid aortic valve; primary disease of the mitral, tricuspid or pulmonary valve; aortic regurgitation of more than a moderate degree; bacterial endocarditis or previous valve surgery. Because this was a natural history study, patients were excluded from analysis if they underwent aortic valve replacement during the 1st 180 days after cardiac catheterization.
One hundred thirty patients met the initial criteria; of these, 64 underwent aortic valve replacement for clinical reasons in the 1st 180 days after cardiac catheterization. The remaining 66 patients formed the final study group. Retrospective record review was carried out for each of these patients. Historical information included age when the murmur was first detected, history of prior myocardial infarction, presence or absence of other diseases including hypertension, diabetes mellitus. cerebrovascular disease and cancer, impression of the severity of the aortic stenosis before cardiac catheterization and onset and severity (by New York Heart Association functional class) of dyspnea, chest pain and syncope if present. Left ventricular hypertrophy on the electrocardiogram (ECG) (21) and cardiomegaly (cardiothoracic ratio >0.5) on the chest radiograph were recorded.
Patient groups were subdivided into those with significant symptoms (class III or IV) at baseline study and those with minimal symptoms. Biplane left ventriculography was performed in 64 patients, allowing quantitation of ejection fraction, stroke volume index and left ventricular end-systolic and enddiastolic volume indexes (23) . Cineventriculograms were used to determine the presence and degree of mitral regurgitation (24) .
Coronary arteriography was performed in all 66 patients. Significant coronary artery disease was defined as ;::::70% luminal diameter narrowing by visual estimation. Patients were considered to have mild, moderate or severe coronary artery disease if significant intraluminal obstruction was present in one, two or three major epicardial vessels.
Patient outcome. Follow-up information for all 66 patients was obtained by telephone interview or review of medical records. This information included vital status and the presence and degree of symptoms in living patients. In those patients who underwent subsequent aortic valve replacement, the timing and indication or indications for operation were obtained. For those patients known to have died, the cause of death was obtained from autopsy records. death certificates, physician records or conversations with the patient's physician. Patients were considered to have died as a result of aortic stenosis (referred to as aortic stenosis-related death) if they died from congestive heart failure or sudden death in the absence of documented myocardial ischemia or infarction. A subset of patients referred to as having aortic stenosis complications included all patients who either underwent aortic valve replacement > 180 days after cardiac catheterization or had an aortic stenosis-related death.
Statistical analysis. Descriptive baseline characteristics were summarized by frequencies and percentages or by mean values and standard deviation. Intergroup comparisons of baseline characteristics were based on two-sample t tests or on the chi-square for two by two tables. Year by year cumulative event-free probabilities were estimated by the Kaplan-Meier survival method and compared between groups by using Greenwood's formula.
The analysis of predictors of development of aortic stenosis complications was based on univariate and multivariate proportional hazards models as well as stratified KaplanMeier curves and log-rank tests for two-group comparisons. Specific p values are reported; p < 0.05 was used informally as the criterion of significance.
Results
Clinical characteristics (Table 1) . Of the 66 patients, 51 (77%) were men. The mean (± SD) age at entry into the study was 67 ± 10 years and the mean age at recognition of the murmur of aortic stenosis was 52 ± 21 years. Only a minority (18%) of the patients were asymptomatic; 62% had dyspnea and 42% were in New York Heart Association functional class III or IV. Syncope was present in only nine patients (14%). Thirty-three percent had left ventricular hypertrophy on the ECG and 23% had cardiomegaly on their chest radiograph. Most patients (80%) were thought to have moderate aortic stenosis on the basis of clinical examination before cardiac catheterization. The clinician overestimated more frequently than undere5timated (14% versus 6%) the severity of aortic stenosis a~defined by our valve area criterion.
Cardiac catheterization ( Table 2 ). The mean calculated aortic valve area was 0.92 ± 0.13 cm 2 , with a mean peak to peak transvalvular gradient of 33 ± 11 mm Hg. At the time of cardiac catheterization, the mean heart rate was 79 beats/min (range 58 to 104). In two patients the heart rate was <60 beats/min and in two it was> 100 beats/min. Mean left ventricular end-diastolic pressure and end-systolic and end-diastolic volume indexes were moderately increased, and the mean cardiac output, ejection fraction and stroke volume were normal. Mild mitral regurgitation was found more frequently than moderate mitral regurgitation; mild and moderate aortic insufficiency were similar in frequency. Coronary artery disease was present in 38 patients; of 18 patients with two or more disl~ased vessels, 9 (50%) had a decreased ejection fraction «50%). Among the 41 patients with one or no vessel diseas{:, 12 (29%) had a decreased ejection fraction.
Patient outcome. Follow-up data for all 66 patients were obtained at a mean of 35 months (maximum 7.2 years). At the end of each of the first 4 years of follow-up study, 58, 44, 36 and 20 patients, respectivel). were available for analysis. During the follow-up period, 14 patients (21%) died from causes attributed to aortic stenosis. During the same period, 21 patients (32%) underwent aortic valve replacement, 13 (62%) because of symptomatic progression and 8 (38%) because of symptomatic progreision and documented hemodynamic progression of disease.
Aortic stenosis complicatioJlls (Tables 3 and 4) . These complications consisted of dehth from aortic stenosis and aortic valve replacement. The estimated probability of remaining free of aortic stenosis complications was 90%, 76%, 66% and 59% at the end of each of the 1st 4 years of follow-up, respectively (Fig. l) Univariate and multivariate predictors of the development of complications related to aortic stenosis are listed in Table 3 . Statistically significan:: univariate predictors were ejection fraction. aortic valve area index, left ventricular end-diastolic pressure and left ventricular end-systolic and end-diastolic volume indexes. By forward stepwise propor- tional hazards regression analysis, ejection fraction, left ventricular end-diastolic pressure and aortic valve area index were independently predictive of aortic stenosis complications. For a better description of the association between aortic stenosis complication rates and baseline left ventricular enddiastolic pressure, ejection fraction, left ventricular endsystolic and end-diastolic volume indexes and aortic valve area index, we dichotomized each variable and compared the hazard rate of aortic stenosis complications in the groups falling above and below each threshold. For example, ejection fraction was dichotomized at 50%, left ventricular end-diastolic pressure at 18 mm Hg, left ventricular end-systolic volume index at 50 mUm 2 , left ventricular end-diastolic volume index at 100 mUm 2 and aortic valve area index at 0.5 cm 2 /m 2 • The relative hazard and 95% confidence intervals are shown in Table 4 . Each of these variables was slightly associated with increased risk of aortic stenosis complications. The relative risk was on the order of 2 to 3 in each case.
Symptomatic versus minimally symptomatic patients. The patients were classified into two groups on the basis of the New York Heart Association functional classification: 1) 38 patients who were symptomatic with a history of syncope or class III or IV dyspnea or chest pain, and 2) 28 patients who were minimally symptomatic without a history of syncope and with class 0, I or II dyspnea or chest pain. The clinical characteristics ( Table 1 ) and findings at cardiac catheterization (Table 2) were compared for the patients in the symptomatic and minimally symptomatic groups. There was a statistically significant difference (p = 0.03) in the severity of coronary artery disease between the patients in the symptomatic and minimally symptomatic groups. With this exception, there were no statistically significant differences in clinical characteristics or findings at cardiac catheterization between these two groups.
The actuarial rates of survival free of aortic stenosis complications for these two subgroups are presented in Figure 2 . The cumulative event rates were higher in the symptomatic group throughout the 4 years, achieving statistical significance (p = 0.022) at year 2.
The actuarial rates of survival free of aortic stenosis MODERATE AORTIC STENOSIS complications are presented in Figure 3 for patients with an ejection fraction ;:::50% and <50%. A significant difference (p == 0.04) in aortic stenosis complication rates, higher in patients with ejection fraction <50%, was observed at 4 years and a marginally significant difference (p == 0.063) was observed at 1 year.
The actuarial survival rates free of aortic stenosis complications for patients with symptoms or ejection fraction <50% and for the remaining patients are shown in Figure 4 . A significant difference (p == 0.03) was observed at 2 years and less significant differences were seen at 3 and 4 years (p == 0.065 and 0.066, respectively).
Aortic stenosis death. Table 5 gives the I, 2, 3 and 4 year probabilities of avoiding death for symptomatic and minimally symptomatic patients. The cumulative death rates were significantly different (p < 0.05) at 1, 2 and 3 years. However, because of the experience beyond 4 years, the overall log-rank test attained only marginal significance (p == 0.106).
In a similar comparison for patients with either symptoms or low ejection fraction «50%) ( 
Discussion
Natural history of aortic stenosis. In clinical studies (6-12) of the natural history of aortic stenosis before the availability of cardiac catheterization, patients with symptomatic aortic stenosis were found to have a high mortality rate, but these studies lacked objective hemodynamic information. Studies (4, 5, (13) (14) (15) (16) (17) (18) (19) (20) 25) performed after the availability of cardiac catheterization and aortic valve replacement attempted to define the natural history of aortic stenosis, but have been criticized for containing only small groups of highly selected patients. In those reports, the rate of progression of aortic stenosis was variable and unpredictable, probably as a result of patient selection bias or lack of complete data from cardiac catheterization. Furthermore, those studies are even less applicable to current patients because of a marked change in the cause of aortic stenosis in recent years-from rheumatic heart disease to bicuspid and senile calcific degeneration (26) .
Since the availability of aortic valve replacement, a true prospective study of the natural history of aortic stenosis has not been possible because this natural history is interrupted by aortic valve replacement in many patients. Because of the limited number of patients available for analysis, some studies (4, (13) (14) (15) (16) (17) (18) (19) (20) retrospectively identified the natural history of patients who refused or were denied aortic valve replacement. The natural history of this small subset of patients with aortic stenosis probably would not represent the natural history of all patients with aortic stenosis.
Definition of severity of aortic stenosis. A problem that has arisen in clinical practice is the definition of "severe" aortic stenosis. In the natural history studies (6-12) performed before the routine use of cardiac catheterization, the diagnosis of the severity of aortic stenosis was made on the basis of clinical examination. These natural history studies may have included patients with catheter-defined less severe stenosis in the group defined as having severe aortic stenosis.
As cardiac catheterization evolved and provided an objective measurement of the severity of aortic stenosis by means of the "aortic valve area," the criterion for severe aortic stenosis was set as an aortic valve area <0.7 cm 2 (20, 25) , and it is now common to offer aortic valve replacement to symptomatic patients who meet this criterion (27) . However, it remains unclear how to treat patients with a valve area larger than this arbitrary value.
The data presented here support the concept that the valve area should not be used as a single final criterion in determining who should be a candidate for aortic valve replacement. The overall mortality rate in patients with ence between the rates of aortic stenosis death in the symptomatic and minimally symptomatic groups. Therefore, our data suggest that the presence of symptoms increases the likelihood of aortic stenosis complications, but the absence of moderate or severe symptoms does not necessarily ensure a favorable prognosis for patients with moderate aortic stenosis. Left ventricular dysfunction. Apparent pathophysiologic consequences of aortic stenosis occurred in our patients, including moderate increases in mean left ventricular enddiastolic pressure and left ventricular end-systolic and endsystolic volume indexes. Despite the presence of these compensatory responses to left ventricular outflow obstruction, the mean ejection fraction and cardiac output were normal in both groups. Altholgh aortic stenosis complications developed in 31 % of patients with an ejection fraction 2':50%, the rate of such complications was higher in those with an ejection fraction <50%. Patients with an abnormally low ejection fraction at initial cardiac catheterization had a 64% chance of aortic stenosis complications developing during the 1st 4 years of follow-up study. Although most of our patients had normal or near normal left ventricular function at entry into the study, those with an ejection fraction ::;50% had a worse prognosis.
Limitations. Patients were eligible for entry into the current study if moderate aortic stenosis was demonstrated at cardiac catheterization between 1980 and 1985. As with other retrospective studies, there was the potential for selection bias, and patients would not have been included in this study if moderate aortic~;tenosis had not been documented at cardiac catheterization. It is reassuring that 80% of our patients were suspected to have moderate aortic stenosis before cardiac catheterization and, when this clinical diagnosis was incorrect, the clinician more often overestimated the severity of aortic stenosis. The formula of Hakki et al. (22) may be less accurate than the Gorlin formula for the calculation of aortic valve area at the extremes of heart rate (29, 30) . At the time of carciac catheterization, only 6% of the patients had a heart rate <60 or > 100 beats/min. This finding suggests that misclassification of patients because of inaccuracies in aortic valve area calculated by using heart rate occurred infrequently. moderate aortic stenosis who already have symptoms approaches that in symptomatic patients with severe aortic stenosis. Therefore, aortic valve replacement should be offered to these patients just as it would be to patients with an aortic valve area <0.7 cm
•
Use of aortic valve area index. Analysis using the aortic valve area alone did not predict development of aortic stenosis complications in this study. There are important ramifications of body size with regard to calculated aortic valve area in an individual patient with aortic stenosis, just as cardiac index provides more information than does cardiac output in many cases. In the patients described here, the aortic valve area index, but not the aortic valve area, predicted the development of aortic stenosis complications.
Relation of symptoms to outcome. From our results, symptomatic patients had a greater incidence of events related to progressive aortic stenosis as reflected by a lower actuarial survival free of aortic stenosis complications and aortic stenosis death during the first 4 years of follow-up study. Others (28) have demonstrated, in studies including those using Doppler echocardiography, the significant risk of cardiac complications related to symptomatic aortic stenosis. However, it is important to note that 31 %of the patients in our minimally symptomatic group had aortic stenosis complications in the first 4 years of follow-up study. In addition, at the end of each of the first 3 years of follow-up study, there was a statistically significant (p < 0.05) differ- We could not eliminate the possibility that coronary artery disease rather than aortic stenosis may have played a role in the left ventricular dysfunction or caused the symptoms, Patients with significant coronary artery disease had more severe left ventricular dysfunction as well as a higher incidence of symptoms. The presence of coronary artery disease was significantly associated with the overall mortality rate during follow-up (p = 0.04). However, by itself, coronary artery disease was not even remotely associated with the primary end point of aortic stenosis-related death or valve replacement in these patients.
Conclusions. Patients with moderate aortic stenosis are at significant risk of complications in the short-term follow-up period. Those with a subnormal ejection fraction and symptoms are at an even higher risk, but the absence of these findings does not necessarily ensure a favorable prognosis. Therefore, valve area should not be used as the sole criterion in determining who is a candidate for valve operation.
